SIS
INSM icon

Strategic Investment Solutions’s Insmed INSM Stock Holding History

Strategic Investment Solutions’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,040
Closed -$79.3K – 642
2025
Q1 		$79.3K Buy
+1,040
New +$79.6K 0.02% 161

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Strategic Investment Solutions's INSM Position: Q2 2025 in Review

Strategic Investment Solutions sold out of Insmed (INSM) in Q2 2025, closing a stake of 1,040 shares — an estimated $79.3K sold.

Strategic Investment Solutions first reported a position in INSM in Q1 2025 and held it in 1 quarter. The position peaked at $79.3K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Strategic Investment Solutions reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 1,040 Insmed shares in Q2 2025, an estimated $79.3K.
  • Strategic Investment Solutions first reported a position in Insmed in Q1 2025 and held it in 1 quarter.
  • Strategic Investment Solutions's Insmed position peaked at $79.3K in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Strategic Investment Solutions's 13F filing for Q2 2025, filed 16 Jul 2025.